Expression of DOG1 in peripheral blood cells of patients with gastrointestinal stromal tumor
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 22 (2) , 99-103
Abstract
No abstract availableKeywords
Funding Information
- Jiangxi Provincial Department of Science and Technology (2015BAB215007, 20161BAB205264)
This publication has 12 references indexed in Scilit:
- Circulating tumor cells as a prognostic and predictive marker in gastrointestinal stromal tumors: a prospective studyOncotarget, 2016
- Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutationsBMC Cancer, 2016
- Study on Clinicopathological Features of Gastrointestinal Stromal Tumor and Relevant Prognostic FactorsCell Biochemistry and Biophysics, 2015
- Gastrointestinal Stromal Tumor Surgery and Adjuvant TherapySurgical Clinics of North America, 2011
- The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literatureBreast Cancer Research and Treatment, 2011
- DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal TumorsAmerican Journal of Surgical Pathology, 2009
- A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal TumorsAmerican Journal of Surgical Pathology, 2008
- Combined Surgical and Molecular TherapyAnnals of Surgery, 2006
- Gastrointestinal stromal tumors: CT and MRI findingsEuropean Radiology, 2005
- The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation StatusThe American Journal of Pathology, 2004